CMS releases details on billing for expanded use of Moderna, J&J boosters
The Centers for Medicare & Medicaid Services Friday released Medicare Part B billing codes and payment allowances for reporting and administering single booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines to eligible adults as authorized Oct. 22 by the Food and Drug Administration.
Authorized COVID-19 booster doses are covered without cost sharing for eligible Medicare, Medicaid, Children's Health Insurance Program and commercial health plan beneficiaries, CMS said.
Related News Articles
Headline
The net prices of five drugs included in a new study from the Institute for Clinical and Economic Review increased without clinical justification in 2023.…
Headline
An analysis by KFF released last week found that in 2022, Medicare spent 27% ($2,585) more, on average, for individuals covered by Traditional Medicare after…
Headline
The AHA Dec. 9 said it supports a potential Medicare $2 Drug List Model, where people enrolled in a Part D plan would have access to certain prescription drugs…
Headline
In comments Dec. 9 to the Medicare Payment Advisory Commission, the AHA shared its views on physician fee schedule payments, advanced alternative payment model…
Headline
The AHA commented Nov. 26 on the Centers for Medicare & Medicaid Services’ hospital inpatient prospective payment system interim final action on revising…
Headline
The Centers for Medicare & Medicaid Services Nov. 21 announced the allocation of 200 new Medicare-funded residency slots to more than 100 teaching…